April 2020 | Volume 1
MOVING INTELLIGENT CHANGE FORWARD
INNOVATION DIGEST
Sifting through so many papers and news items about our collective battle with an unseen and unending viral foe, it’s easy to be overloaded and, let’s be honest, jaded about what this all means for our health system future-state. I think there are glimmers of hope that we can all attach to in this time of uncertainty. I can’t recall a time when the importance of both mental and physical wellness is more tangible to all of us, irregardless of race, age, gender, economic status or geography. We are learning that solutions to all kinds of problems in healthcare, from accessibility to supply chain, require creativity, flexibility, transparency and shared, all-in effort. And we’re learning (or remembering) that health care has both a prevention and a care (in both treatment and dignity sense) aspect that requires commitment and investment. We aren’t yet certain when we “return to normal,” but I’m hopeful that “normal” is redefined by this experience. The opportunity to improve our policy,research, public health and care delivery is real. I hope to see and contribute to such monumental change.
To Help Develop The Safest, Most Effective Coronavirus Tests, Treatments, And Vaccines, Ensure Public Access To Clinical Research Data
To address the  COVID-19  pandemic that is bearing down on the United States, the public urgently needs new diagnostics, treatments, and vaccines. However, to be confident that any new technologies are safe and effective, we need public access to clinical research data and other information on these technologies. As President Trump, Congress, the FDA, CDC, NIH, and other parts of government move quickly to fight COVID-19, they should make clinical research data transparency a high-level priority and commit to data sharing as a condition of clinical research funding and product clearance and approval.
The Coronavirus Pandemic Could Transform Our Health Care System -- For The Better
The Covid-19 pandemic has rapidly disrupted our everyday life. Cities and states are on lockdown in a desperate effort to flatten the curve. Worst-case scenario projections are dire, with the potential for millions of deaths in the absence of immediate, decisive, and coordinated action. The virus threatens to overwhelm our health care system while frontline medical professionals lack the equipment needed to protect themselves from infection.
Health-care Rationing is a Choice We're Already Making
In COVID-19 hotspots around the country, state health authorities are distributing rationing plans, anticipating too many patients and not enough critical care equipment. Alabama’s plan would restrict children and adults with intellectual and cognitive disabilities from getting ventilators. The Washington State Health Department suggests transferring patients out of the hospital or to palliative care if their baseline functioning is marked by “loss of reserves in energy, physical ability, cognition and general health.”

This pick-and-choose approach to health care isn’t unique to coronavirus. It’s been playing out for years in our health care system.
A NICE Transformation?
Pressure is building in the regulatory arena as advancing biomedical innovation surpasses the methods and processes used in evaluation. That pressure has now come to a head with the latest NICE methods review, where the industry is hoping for answers that will deliver a system built for innovation and personalisation. But what can this review reasonably achieve?
America Can Afford a World-Class Health System. Why Don't We Have One?
In March, Congress passed a coronavirus bill including $3.1 billion to develop and produce drugs and vaccines. The bipartisan consensus was unusual. Less unusual was the successful lobbying by pharmaceutical companies to weaken or kill provisions that addressed affordability — measures that could be used to control prices or invalidate patents for any new drugs.

Passion + Quality = Change That Matters
  
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.

Momentum Health Strategies

Jennifer L Bright, MPA
(703) 628 - 0534
STAY CONNECTED